Pfizer Limited Stock price Bombay S.E.

Equities

PFIZER

INE182A01018

Pharmaceuticals

Delayed Bombay S.E. 03:41:09 2024-03-19 am EDT 5-day change 1st Jan Change
4,354 INR +0.54% Intraday chart for Pfizer Limited +0.89% +2.01%
Sales 2024 * 22.01B 265M Sales 2025 * 23.81B 287M Capitalization 198B 2.39B
Net income 2024 * 5.02B 60.49M Net income 2025 * 5.88B 70.89M EV / Sales 2024 * 9.02 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 8.34 x
P/E ratio 2024 *
39.6 x
P/E ratio 2025 *
33.8 x
Employees 1,702
Yield 2024 *
1.18%
Yield 2025 *
1.09%
Free-Float 33.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.54%
1 week+0.89%
Current month-5.31%
1 month-5.32%
3 months+2.81%
6 months+11.99%
Current year+2.01%
More quotes
1 week
4 199.55
Extreme 4199.55
4 401.65
1 month
4 199.55
Extreme 4199.55
4 676.35
Current year
4 141.15
Extreme 4141.15
4 838.90
1 year
3 406.95
Extreme 3406.95
4 838.90
3 years
3 406.95
Extreme 3406.95
6 164.80
5 years
2 797.50
Extreme 2797.5
6 164.80
10 years
1 166.00
Extreme 1166
6 164.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 53 23-04-02
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - -
Members of the board TitleAgeSince
Chairman 71 99-12-06
Director/Board Member 74 12-05-20
Director/Board Member 64 15-02-13
More insiders
Date Price Change Volume
24-03-19 4,354 +0.54% 669
24-03-18 4,331 -1.11% 765
24-03-15 4,380 +3.06% 543
24-03-14 4,249 -0.41% 2,684
24-03-13 4,267 -1.13% 3,292

Delayed Quote Bombay S.E., March 19, 2024 at 03:41 am EDT

More quotes
Pfizer Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company has its own manufacturing facility at Goa. The Company has various independent contract/third party manufacturers based across India. Its product portfolio includes vaccine, anti-infectives, cardiac, pain, maternal nutrition, gastrointestinal, contraceptives, anti-inflammatory, nutrition and immunity, and respiratory. The Company's vaccine business is focused on Prevenar 13, a pneumococcal conjugate vaccine that is administered to infants who are six weeks and older as part of primary vaccination, toddlers, adolescents, adults, and elderly population. Its inflammation and immunology portfolio includes two advanced therapies, which cater to patients suffering from diseases related to chronic immune system such as rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, psoriasis and ulcerative colitis.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Pfizer Limited
  4. Stock Pfizer Limited - Bombay S.E.